ICLR
ICON PLC
NASDAQ: ICLR · HEALTHCARE · DIAGNOSTICS & RESEARCH
$118.33
+1.86% today
Updated 2026-04-30
Market cap
$9.03B
P/E ratio
15.66
P/S ratio
1.12x
EPS (TTM)
$7.42
Dividend yield
—
52W range
$67 – $211
Volume
1.3M
ICON PLC (ICLR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
7.40%
Operating margin
12.70%
ROE
6.27%
ROA
4.20%
Debt/equity
0.38x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2005 | $346.20M | $12.72M | 36.45% | 5.72% | 3.67% |
| 2006 | $455.60M | $38.30M | 43.75% | 10.50% | 8.41% |
| 2007 | $630.72M | $55.96M | 43.80% | 10.98% | 8.87% |
| 2008 | $865.25M | $78.12M | 43.46% | 11.50% | 9.03% |
| 2009 | $887.61M | $94.30M | 42.79% | 12.11% | 10.62% |
| 2010 | $900.04M | $87.07M | 39.85% | 10.23% | 9.67% |
| 2011 | $945.73M | $22.88M | 35.30% | 4.15% | 2.42% |
| 2012 | $1.12B | $55.42M | 35.59% | 6.50% | 4.97% |
| 2013 | $1.34B | $102.81M | 36.72% | 9.07% | 7.70% |
| 2014 | $1.50B | $172.47M | 39.92% | 13.46% | 11.47% |
| 2015 | $1.57B | $239.54M | 42.29% | 17.88% | 15.21% |
| 2016 | $1.67B | $262.18M | 42.31% | 18.70% | 15.73% |
| 2017 | $1.76B | $281.49M | 41.34% | 19.24% | 16.01% |
| 2018 | $2.60B | $322.82M | 29.64% | 14.38% | 12.44% |
| 2019 | $2.81B | $373.99M | 29.64% | 15.45% | 13.33% |
| 2020 | $2.80B | $327.81M | 28.89% | 14.00% | 11.72% |
| 2021 | $5.48B | $153.19M | 27.52% | 6.91% | 2.79% |
| 2022 | $7.74B | $505.30M | 28.60% | 10.27% | 6.53% |
| 2023 | $8.12B | $612.34M | 29.56% | 11.78% | 7.54% |
| 2024 | $8.28B | $791.47M | 29.42% | 13.26% | 9.56% |